VP-339

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameVP-339
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V2 receptor antagonists
TargetsVasopressin V2 receptor
Therapy Area/IndicationsHyponatremiaHypertensionHeart Failure +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWakamoto
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWakamoto
Active IndicationsN/A
Inactive IndicationsHyponatremiaHypertensionHeart Failure +[4] 

Other Information

ATC CodeN/A
Related LinksN/A